IPOT — Isracann Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro Cap

Annual balance sheet for Isracann Biosciences, fiscal year end - May 31st, CAD millions except per share, conversion factor applied.

	2018 May 31st	2019 May 31st	2020 May 31st	2021 May 31st	2022 May 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	7.98	4.18	3.89	1.96	0.214
Net Total Accounts Receivable
Net Total Receivables	0.097	0.682	0.243	0.208	0.083
Prepaid Expenses
Total Other Current Assets
Total Current Assets	9.37	15.4	5.48	2.25	0.345
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	5.19	0.893	0.117	0.089	0.048
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	14.6	16.4	28.3	4.4	4.09
Payable / Accrued
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.897	1.04	1.72	0.465	0.915
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	0.897	1.04	1.72	0.462	3.8
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	13.7	15.3	26.6	3.94	0.294
Total Liabilities & Shareholders' Equity	14.6	16.4	28.3	4.4	4.09
Total Common Shares Outstanding